News Daily News NOACs Significantly Curb Risk of VTE in Cancer Patients L.A. McKeown December 06, 2018
News Daily News Higher Rates of Amputation and Ketoacidosis With SGLT2 Inhibitors: European Registry Data Michael O'Riordan November 26, 2018
News Opinion Conversations in Cardiology Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC? November 16, 2018
News Daily News Automated Email Reminders May Boost IVC Filter Retrieval, Cut Complications Todd Neale October 23, 2018
News Daily News More Research Supports Use of Aspirin Alone to Prevent VTE After Knee Replacement Surgery L.A. McKeown October 18, 2018
News Daily News New-Onset A-fib Following Noncardiac Surgery: Beware the Thromboembolic Risk Yael L. Maxwell October 16, 2018
News Conference News ESC 2018 My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More Shelley Wood September 14, 2018
News Daily News Good INR Control on Warfarin Doesn’t Necessarily Predict Future Success, Outcomes Todd Neale September 13, 2018
News Conference News ESC 2018 Updated ESC Guidelines Introduce Concept of a Pregnancy Heart Team for Women With CVD Todd Neale August 31, 2018
News Conference News ESC 2018 MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis Todd Neale August 26, 2018
News Daily News AHA Scientific Statement Aims to Raise Awareness of Chagas Disease and Risk for Cardiomyopathy Lucy Hicks August 24, 2018
News Conference News ESC 2018 ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More Shelley Wood August 20, 2018
News Daily News Intracranial Hemorrhage Outside of A-fib: Different NOACs, Different Risks Todd Neale August 13, 2018
News Daily News New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI Michael O'Riordan July 31, 2018
News Daily News Bleeding Risk Increased With NSAID Use in Anticoagulated A-fib Patients: RE-LY Analysis L.A. McKeown July 10, 2018
News Daily News Real-world Analysis Suggests Apixaban Is Safest of the NOACs, Even for Patients With A-fib L.A. McKeown July 06, 2018
News Daily News Burden of Anticoagulation Can Be Reduced in Some Patients With Mechanical Valves L.A. McKeown June 12, 2018
News Daily News Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval Todd Neale May 04, 2018
News Daily News Postoperative A-fib Not as Bad as Nonsurgical A-fib for Thromboembolism Todd Neale March 29, 2018